X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (5111) 5111
humans (4981) 4981
bevacizumab (3512) 3512
intravitreal injections (3398) 3398
male (3372) 3372
female (3263) 3263
ranibizumab (2540) 2540
aged (2472) 2472
vascular endothelial growth factor a - antagonists & inhibitors (2378) 2378
middle aged (2267) 2267
macular degeneration (2024) 2024
angiogenesis inhibitors - therapeutic use (1854) 1854
angiogenesis inhibitors - administration & dosage (1731) 1731
tomography, optical coherence (1716) 1716
vascular endothelial growth factor (1596) 1596
treatment outcome (1575) 1575
intravitreal bevacizumab (1558) 1558
endothelial growth-factor (1512) 1512
retrospective studies (1486) 1486
fluorescein angiography (1400) 1400
aged, 80 and over (1377) 1377
visual acuity (1319) 1319
eye diseases (1230) 1230
visual acuity - physiology (1214) 1214
follow-up studies (1194) 1194
diabetic retinopathy (1055) 1055
adult (1006) 1006
genetic structures (976) 976
intravitreal injection (954) 954
macular edema - drug therapy (934) 934
injection (899) 899
retina (892) 892
prospective studies (870) 870
photodynamic therapy (812) 812
choroidal neovascularization (807) 807
choroidal neovascularization - drug therapy (789) 789
care and treatment (787) 787
optical coherence tomography (786) 786
antibodies, monoclonal, humanized (770) 770
antibodies, monoclonal, humanized - therapeutic use (765) 765
edema (757) 757
sense organs (748) 748
macular edema (745) 745
antibodies, monoclonal, humanized - administration & dosage (725) 725
therapy (714) 714
neovascularization (697) 697
age-related macular degeneration (685) 685
avastin (669) 669
wet macular degeneration - drug therapy (666) 666
diabetes (638) 638
macular degeneration - drug therapy (633) 633
diabetic retinopathy - drug therapy (609) 609
retinopathy (599) 599
medicine & public health (595) 595
animals (568) 568
diabetic macular edema (527) 527
surgery (516) 516
angiogenesis inhibitors - adverse effects (507) 507
patients (502) 502
macular edema - etiology (498) 498
vegf (488) 488
analysis (487) 487
verteporfin (476) 476
aflibercept (475) 475
age (475) 475
physiological aspects (471) 471
time factors (463) 463
eye (462) 462
triamcinolone (460) 460
research (444) 444
drug therapy (435) 435
bevacizumab - administration & dosage (429) 429
antibodies, monoclonal - administration & dosage (428) 428
vitrectomy (426) 426
bevacizumab - therapeutic use (414) 414
risk factors (412) 412
safety (412) 412
pharmacology & pharmacy (408) 408
efficacy (405) 405
fundus oculi (401) 401
anti-vegf (397) 397
ranibizumab - administration & dosage (396) 396
injections (395) 395
retina - pathology (388) 388
abridged index medicus (385) 385
triamcinolone acetonide (378) 378
ranibizumab - therapeutic use (373) 373
retinal vein occlusion - drug therapy (365) 365
visual acuity - drug effects (365) 365
antibodies, monoclonal - therapeutic use (359) 359
retinal vein occlusion (359) 359
secondary (359) 359
angiogenesis (356) 356
studies (353) 353
choroidal neovascularization - etiology (350) 350
macular edema - diagnosis (345) 345
medical imaging (345) 345
intravitreal bevacizumab avastin (343) 343
endothelial growth factors (341) 341
angiogenesis inhibitors (340) 340
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6461) 6461
German (209) 209
French (89) 89
Korean (48) 48
Spanish (41) 41
Turkish (26) 26
Japanese (23) 23
Portuguese (18) 18
Polish (8) 8
Romanian (6) 6
Russian (4) 4
Czech (3) 3
Chinese (2) 2
Slovenian (2) 2
Swedish (2) 2
Hungarian (1) 1
Italian (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 06/2016, Volume 123, Issue 6, pp. 1351 - 1359
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 13, pp. 1193 - 1203
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2017, Volume 317, Issue 20, pp. 2072 - 2087
Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 7, pp. 1399 - 1411
Purpose To compare the efficacy and safety of ranibizumab and bevacizumab intravitreal injections to treat neovascular age-related macular degeneration (nAMD... 
Ophthalmology | DIABETIC-RETINOPATHY | OPHTHALMOLOGY | AVASTIN | DESIGN | INTRAVITREAL BEVACIZUMAB | Macular degeneration | Chronic diseases | Angiogenesis inhibitors | Universities and colleges
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 9, p. CD011230
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 08/2016, Volume 134, Issue 8, pp. 888 - 896
Journal Article
Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 2017, Volume 37, Issue 10, pp. 1847 - 1858
Purpose: To evaluate the systemic pharmacokinetics (PKs) of aflibercept, bevacizumab, and ranibizumab in patients with neovascular age-related macular degeneration (AMD... 
anti-VEGF | pharmacokinetics | retinal vein occlusion | age-related macular degeneration | diabetic macular edema | INTRAOCULAR PHARMACOKINETICS | RANDOMIZED-TRIAL | EXTEND PROTOCOL | PLASMA-LEVELS | SERUM VEGF | OPHTHALMOLOGY | VEGF TRAP | MONOCLONAL-ANTIBODIES | ENDOTHELIAL GROWTH-FACTOR | Diabetic Retinopathy - drug therapy | Prospective Studies | Follow-Up Studies | Intravitreal Injections | Ranibizumab - pharmacokinetics | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Angiogenesis Inhibitors - administration & dosage | Female | Recombinant Fusion Proteins - administration & dosage | Bevacizumab - administration & dosage | Enzyme-Linked Immunosorbent Assay | Vascular Endothelial Growth Factor A - blood | Bevacizumab - pharmacokinetics | Angiogenesis Inhibitors - pharmacokinetics | Macular Edema - blood | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Wet Macular Degeneration - diagnosis | Diabetic Retinopathy - blood | Wet Macular Degeneration - drug therapy | Recombinant Fusion Proteins - pharmacokinetics | Macular Edema - drug therapy | Wet Macular Degeneration - blood | Ranibizumab - administration & dosage | Aged | Drug therapy | Retinal diseases | Original Study
Journal Article